Q-Line Biotech IPO: The initial public offering of healthcare solutions provider Q-Line Biotech will conclude on Monday, May 25. The subscription details for the final day will be available post-10 am.
As of day 2, the issue has been subscribed to 9.17 times. It has received bids for 4,10,13,600 shares, compared with 44,72,000 shares on offer, according to the NSE website.
The ₹214.48 crore book-build issue, with a price band of ₹326 to ₹343 per share, is solely a fresh issuance of 62.53 lakh shares, without an offer for sale (OFS) component.
The funds generated will be utilised for working capital needs, debt clearance and corporate general purposes.
A lot consists of 400 shares, and the minimum investment for an individual investor is 800 shares.
The company is engaged in developing, manufacturing and marketing reagents (including kits and POC devices) and consumables and making and supplying diagnostic equipment for various diagnostic healthcare needs.
Q-Line Biotech IPO: Allotment and listing date
Q-Line Biotech IPO allotment status is expected to be finalised on May 26, while listing on the NSE SME platform, Emerge, is likely to take place on May 29.
How to check Q-Line Biotech IPO allotment status on NSE
- Go to NSE’s allotment status page: https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids
- Pick ‘Equity & SME IPO bid details’
- Choose ‘Q-Line Biotech’ under the symbol ‘QLINE’.
- Enter your PAN details and application number.
- Click on submit
Steps to check Q-Line Biotech IPO allotment status on Purva Sharegistry India
- Visit the registrar’s website: https://www.purvashare.com/investor-service/ipo-query
- Choose ‘Q-Line Biotech’ from the company list
- Enter your PAN details or application number
- Click on Search
Q-Line Biotech IPO GMP
According to investorgain.com and media reports, the unlisted shares of Q-Line Biotec are trading at ₹468 per share, reflecting a grey market premium, or GMP, of 36.44% over the upper price band of ₹343.